121 related articles for article (PubMed ID: 16465841)
1. [Better with lower LDL cholesterol! Aim at 2 mmol/l for secondary prevention].
Olsson AG
Lakartidningen; 2006 Jan 11-17; 103(1-2):22-3. PubMed ID: 16465841
[No Abstract] [Full Text] [Related]
2. [Target levels for LDL cholesterol are put out of the running. Cholesterol should be lowered maximally in high cardiovascular risk].
Olsson AG
Lakartidningen; 2011 Jun 1-14; 108(22-23):1240-3. PubMed ID: 21786498
[No Abstract] [Full Text] [Related]
3. [Can higher level of HDL cholesterol augment cardiovascular disease prevention? The combination statins-nicotinic acid increases the level of HDL and reduces the level of LDL cholesterol].
Carlson LA
Lakartidningen; 2006 Oct 25-31; 103(43):3283-5. PubMed ID: 17117660
[No Abstract] [Full Text] [Related]
4. [For coronary disease patients is certain: the lower the LDL the better].
MMW Fortschr Med; 2006 Jun; 148(24):6. PubMed ID: 16850797
[No Abstract] [Full Text] [Related]
5. [Should cholesterol levels be reduced more aggressively?].
Ravnskov U
Lakartidningen; 2005 Sep 12-18; 102(37):2583-4; discussion 2584. PubMed ID: 16200908
[No Abstract] [Full Text] [Related]
6. [Say no to the extremes in the debate on lipid reduction].
Hjemdahl P; Allhammar A; Eklund J; Forslund T; Hulting J; Kahan T; Martinsson A; Malmström R; Rücker F; Schenck-Gustafsson K; Schwieler J; Törnerud M; Wettermark B
Lakartidningen; 2011 Sep 7-13; 108(36):1664-5. PubMed ID: 22032007
[No Abstract] [Full Text] [Related]
7. [Statin and absorption inhibitor work synergistically. More risk patient reach LDL cholesterol goal value].
MMW Fortschr Med; 2007 Apr; 149(17):56-7. PubMed ID: 17674912
[No Abstract] [Full Text] [Related]
8. Time- and dose-dependent effect of psyllium on serum lipids in mild-to-moderate hypercholesterolemia: a meta-analysis of controlled clinical trials.
Wei ZH; Wang H; Chen XY; Wang BS; Rong ZX; Wang BS; Su BH; Chen HZ
Eur J Clin Nutr; 2009 Jul; 63(7):821-7. PubMed ID: 18985059
[TBL] [Abstract][Full Text] [Related]
9. [The new debate on cholesterol: is the lowest level the best?].
Olsson AG
Lakartidningen; 1999 Feb; 96(6):648-52. PubMed ID: 10087815
[No Abstract] [Full Text] [Related]
10. Improve-it: Full disclosures?
Nicot P; Guerbaai RA; Ennezat PV
Int J Cardiol; 2015 Dec; 201():380-1. PubMed ID: 26310982
[No Abstract] [Full Text] [Related]
11. In brief: Zetia and Vytorin: the ENHANCE study.
Med Lett Drugs Ther; 2008 Jan; 50(1278):5. PubMed ID: 18219263
[No Abstract] [Full Text] [Related]
12. [The lower LDL cholesterol the better!].
Stenestrand U; Olsson AG
Lakartidningen; 2004 Oct; 101(42):3246-7. PubMed ID: 15544130
[No Abstract] [Full Text] [Related]
13. Is there a problem with ezetimibe or just ENHANCEd hype?
Whayne TF
Angiology; 2008 Dec-2009 Jan; 59(6):661-3. PubMed ID: 18796445
[No Abstract] [Full Text] [Related]
14. [MMW- Drug Prize 2005 for simvastatin/ezetimib (Inegy). LDL goal values are easier to reach now].
Füessl HS
MMW Fortschr Med; 2005 Oct; 147(43):13. PubMed ID: 16302413
[No Abstract] [Full Text] [Related]
15. Are we lowering LDL cholesterol sufficiently?
Barter P; Rye KA
Nat Clin Pract Cardiovasc Med; 2006 Jun; 3(6):290-1. PubMed ID: 16728988
[No Abstract] [Full Text] [Related]
16. The efficacy of statin monotherapy uptitration versus switching to ezetimibe/simvastatin: results of the EASEGO study.
Roeters van Lennep HW; Liem AH; Dunselman PH; Dallinga-Thie GM; Zwinderman AH; Jukema JW
Curr Med Res Opin; 2008 Mar; 24(3):685-94. PubMed ID: 18226326
[TBL] [Abstract][Full Text] [Related]
17. [An extensive English study: reduced cardiovascular mortality and morbidity by statin].
Nilsson P; Erhardt L
Lakartidningen; 2001 Dec; 98(51-52):5846-50. PubMed ID: 11806257
[No Abstract] [Full Text] [Related]
18. Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe.
Daskalopoulou SS; Mikhailidis DP
Curr Med Res Opin; 2006 Mar; 22(3):511-28. PubMed ID: 16574035
[TBL] [Abstract][Full Text] [Related]
19. [Simvastatin 40 mg as secondary prophylaxis: Effective, tolerable and cost-efficient!].
Hernborg A; Hjemdahl P; Håkansson J
Lakartidningen; 2006 Mar 15-21; 103(11):858, 861; discussion 861-2. PubMed ID: 16613120
[No Abstract] [Full Text] [Related]
20. A dose-specific meta-analysis of lipid changes in randomized controlled trials of atorvastatin and simvastatin.
Rogers SL; Magliano DJ; Levison DB; Webb K; Clarke PJ; Grobler MP; Liew D
Clin Ther; 2007 Feb; 29(2):242-52. PubMed ID: 17472817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
